Auro Laboratories Limited has completed its capacity expansion project for Metformin HCL and other products at its existing manufacturing unit.

The plant is now fully operational again, which strengthens the company’s production capabilities and supports its growth prospects.

This completion is a positive development for shareholders as it enhances the company’s ability to meet increasing demand and improve supply stability.